Skip to main content

Market Overview

BZI-ROCE

  • AI, BZI-ROCE, Earnings

    Looking Into C3.ai's Return On Capital Employed

    Wednesday, May 24, 2023 - 10:48am

    According to data from Benzinga Pro, during Q3, C3.ai's (NYSE:AI) reported sales totaled $66.67 million. Despite a 8.26% increase in earnings, the company posted a loss of $63.16 million. In Q2, C3.ai brought in $62.41 million in sales but lost $68.85 million in earnings. What Is Return On Capital...

    Read More...
  • BZI-ROCE, Earnings, S

    Looking Into SentinelOne's Return On Capital Employed

    Wednesday, May 24, 2023 - 10:48am

    According to data from Benzinga Pro, during Q4, SentinelOne's (NYSE:S) reported sales totaled $126.10 million. Despite a 5.24% increase in earnings, the company posted a loss of $93.68 million. In Q3, SentinelOne brought in $115.32 million in sales but lost $98.86 million in earnings. What Is ROCE...

    Read More...
  • BYD, BZI-ROCE, Earnings

    Boyd Gaming's Return On Capital Employed Insights

    Wednesday, May 24, 2023 - 10:48am

    According to Benzinga Pro, during Q1, Boyd Gaming (NYSE:BYD) earned $199.73 million, a 15.66% increase from the preceding quarter. Boyd Gaming also posted a total of $963.97 million in sales, a 4.45% increase since Q4. Boyd Gaming earned $172.68 million, and sales totaled $922.92 million in Q4. Why...

    Read More...
  • BZI-ROCE, Earnings, OPAL

    OPAL Fuels's Return On Capital Employed Insights

    Wednesday, May 24, 2023 - 10:48am

    Benzinga Pro data, OPAL Fuels (NASDAQ:OPAL) reported Q1 sales of $42.96 million. Earnings fell to a loss of $7.35 million, resulting in a 122.94% decrease from last quarter. In Q4, OPAL Fuels earned $32.02 million, and total sales reached $66.72 million. Why Is ROCE Significant? Return on Capital...

    Read More...
  • BRDS, BZI-ROCE, Earnings

    Bird Glb Earnings Perspective: Return On Invested Capital

    Wednesday, May 24, 2023 - 10:48am

    Bird Glb (NYSE:BRDS) brought in sales totaling $29.54 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 21.73%, resulting in a loss of $44.32 million. In Q4, Bird Glb brought in $69.66 million in sales but lost $36.41 million in earnings. What Is Return On...

    Read More...
  • BZI-ROCE, CTS, Earnings

    CTS Earnings Perspective: Return On Invested Capital

    Wednesday, May 24, 2023 - 10:48am

    According to Benzinga Pro, during Q1, CTS (NYSE:CTS) earned $18.34 million, a 22.78% increase from the preceding quarter. CTS also posted a total of $145.99 million in sales, a 2.61% increase since Q4. CTS earned $14.94 million, and sales totaled $142.28 million in Q4. What Is ROIC? Earnings data...

    Read More...
  • BZI-ROCE, Earnings, K

    Kellogg Earnings Perspective: Return On Capital Employed

    Wednesday, May 24, 2023 - 10:47am

    According to Benzinga Pro, during Q1, Kellogg (NYSE:K) earned $302.00 million, a 402.0% increase from the preceding quarter. Kellogg also posted a total of $4.05 billion in sales, a 5.77% increase since Q4. Kellogg collected $3.83 billion in revenue during Q4, but reported earnings showed a $100.00...

    Read More...
  • BZI-ROCE, Earnings, XOMA

    XOMA's Return On Capital Employed Insights

    Wednesday, May 24, 2023 - 10:47am

    Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $437 thousand. Earnings fell to a loss of $9.81 million, resulting in a 64.21% decrease from last quarter. XOMA collected $1.49 million in revenue during Q4, but reported earnings showed a $5.98 million loss. Why Is ROCE Significant?...

    Read More...
  • BZI-ROCE, Earnings, SGTX

    Sigilon Therapeutics's Return On Capital Employed Overview

    Wednesday, May 24, 2023 - 10:47am

    Sigilon Therapeutics (NASDAQ:SGTX) brought in sales totaling $4.86 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 10.37%, resulting in a loss of $7.38 million. Sigilon Therapeutics collected $2.64 million in revenue during Q4, but reported earnings showed...

    Read More...
  • BZI-ROCE, Earnings, XXII

    22nd Century Group's Return On Capital Employed Overview

    Wednesday, May 24, 2023 - 10:47am

    According to Benzinga Pro data, during Q1, 22nd Century Group (AMEX:XXII) posted sales of $21.96 million. Earnings were up 30.82%, but 22nd Century Group still reported an overall loss of $18.18 million. In Q4, 22nd Century Group brought in $19.21 million in sales but lost $26.28 million in...

    Read More...
  • BZI-ROCE, Earnings, SCSC

    ScanSource's Return On Capital Employed Overview

    Wednesday, May 24, 2023 - 10:47am

    Pulled from Benzinga Pro data, ScanSource (NASDAQ:SCSC) posted Q3 earnings of $21.22 million, an increase from Q2 of 17.54%. Sales dropped to $885.52 million, a 12.41% decrease between quarters. ScanSource reached earnings of $25.73 million and sales of $1.01 billion in Q2. Why Is ROCE Significant...

    Read More...
  • BZI-ROCE, Earnings, LITE

    Looking Into Lumentum Holdings's Return On Capital Employed

    Wednesday, May 24, 2023 - 10:47am

    Benzinga Pro data, Lumentum Holdings (NASDAQ:LITE) reported Q3 sales of $383.40 million. Earnings fell to a loss of $39.30 million, resulting in a 23.97% decrease from last quarter. Lumentum Holdings collected $506.00 million in revenue during Q2, but reported earnings showed a $31.70 million loss...

    Read More...
  • BZI-ROCE, Earnings, MCRB

    Looking Into Seres Therapeutics's Return On Capital Employed

    Wednesday, May 24, 2023 - 10:47am

    Benzinga Pro data, Seres Therapeutics (NASDAQ:MCRB) reported Q1 sales of $-522 thousand. Earnings fell to a loss of $71.17 million, resulting in a 3.46% decrease from last quarter. In Q4, Seres Therapeutics brought in $975 thousand in sales but lost $68.80 million in earnings. What Is Return On...

    Read More...
  • BZI-ROCE, CECO, Earnings

    CECO Environmental Earnings Perspective: Return On Capital Employed

    Wednesday, May 24, 2023 - 10:47am

    According to Benzinga Pro, during Q1, CECO Environmental (NASDAQ:CECO) earned $2.47 million, a 71.16% increase from the preceding quarter. CECO Environmental's sales decreased to $112.56 million, a 3.3% change since Q4. In Q4, CECO Environmental earned $8.56 million, and total sales reached $116.40...

    Read More...
  • BZI-ROCE, Earnings, MRSN

    Mersana Therapeutics's Return On Capital Employed Insights

    Wednesday, May 24, 2023 - 10:46am

    Benzinga Pro data, Mersana Therapeutics (NASDAQ:MRSN) reported Q1 sales of $7.80 million. Earnings fell to a loss of $56.16 million, resulting in a 25.02% decrease from last quarter. In Q4, Mersana Therapeutics brought in $14.69 million in sales but lost $44.92 million in earnings. What Is Return...

    Read More...